IVD Test Reagent/Kits, Microbiology, Bacteria, Identification, Clostridium difficile

Definition : Microbiology reagents intended to identify Clostridium difficile, a bacterium of the family Bacillaceae. Clostridium difficile bacteria are part of the normal colon flora in humans; they grow in large numbers and produce a protein exotoxin in sufficient amounts to cause pseudomembranous enterocolitis in patients receiving certain antibiotic (e.g., lincomycin) treatments.

Entry Terms : "Clostridium Species Detection/Identification Reagents" , "Enterocolitis Diagnostic Reagents" , "Clostridium difficile Detection/Identification Reagents" , "Clostridium difficile Identification Reagents" , "Reagents, Clostridium difficile Toxin" , "Reagents, Microbiology, Bacteria, Identification, Clostridium difficile"

UMDC code : 19501

U.S.companies only
Suppress Subsidiary Companies

1-4 of 4 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

Key Scientific Products Inc

Company Type: Parent

Mayo Medical Laboratories

Company Type: Parent

Nanosphere Inc

Company Type: Parent

Nanosphere develops, manufactures and markets an advanced molecular diagnostic platform, the Verigene System, which enables simple, cost-effective, and highly sensitive nucleic acid (DNA and RNA) and protein testing on a single platform.

1-4 of 4 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone